MPM BioImpact
MPM BioImpact is a biotechnology investment firm focused on creating and investing in innovative companies to deliver transformative therapies. They invest in companies developing breakthrough technologies like next-generation antibodies, radiopharmaceuticals, and cell and gene therapies to address unmet global medical needs, including viral and infectious diseases.
Funding Round: Strategic Investment
Funding Amount: $20M
Date: 09-Jan-2025
Investors: Meiji Seika Pharma
Markets: Biotech, Healthcare, Pharmaceuticals
HQ: Boston, Massachusetts, United States
Founded: 2010
Website: https://mpmbioimpact.com/
LinkedIn: https://www.linkedin.com/company/mpm-capital
Twitter: https://x.com/mpmcapital
Crunchbase: https://www.crunchbase.com/organization/mpm-bioimpact
Leave a Comment
Comments
No comments yet.